Combination Biologic Therapy as Initial Treatment for Follicular Lymphoma: Initial Results From CALGB 50701 - a Phase II Trial of Extended Induction Epratuzumab (anti-CD22) and Rituximab (anti-CD20)
- Citation:
- Blood vol 116 (21) -427
- Meeting Instance:
- ASH 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 1045
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- B. Grant J. P. Leonard J. L. Johnson L. Kostakoglu E. Hsi J. C. Byrd J. A. Jones S.-H. Jung B. D. Cheson
- Networks:
- Study
- CALGB-50701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: